The Seiden Law Announces U.S. Shareholders Formation Of A Group To Recover Investor Funds Through A Possible Receivership Over China-Based Bio-pharm Asia, Inc., (Ticker:BFAR)
BioPharm Asia, Inc., (ticker:”BFAR”), is a Nevada corporation involved in the sale of medical products to drug stores, hospitals, neighborhood clinics, and other medicine retail outlets in the People’s Republic of China. BFAR was de-listed from the NASDAQ in June 2013...
